Hypersensitivity reaction: Difference between revisions
m (Rossdonaldson1 moved page Hypersensitivity Reaction to Hypersensitivity reaction) |
Alexgrohmann (talk | contribs) |
||
(4 intermediate revisions by 3 users not shown) | |||
Line 11: | Line 11: | ||
| II: Cytotoxic, Antibody Dependant || IgG or IgM antibodies react with cell antigens with resultant complement activation || [[Myasthenia gravis]], [[goodpasture syndrome]], erythroblastalis fetalis, AI hemolytic anemia, Graves disease | | II: Cytotoxic, Antibody Dependant || IgG or IgM antibodies react with cell antigens with resultant complement activation || [[Myasthenia gravis]], [[goodpasture syndrome]], erythroblastalis fetalis, AI hemolytic anemia, Graves disease | ||
|- | |- | ||
| III: Immune Complex || IgG immune complex deposition and subsequent complement activation || [[Serum sickness]], RA, [[SLE]], [[ | | III: Immune Complex || IgG immune complex deposition and subsequent complement activation || [[Serum sickness]], RA, [[SLE]], [[poststreptococcal glomerulonephritis]] | ||
|- | |- | ||
| IV: Cell-mediated, Delayed || Activated T cells against cell surface antigens || TB skin test, chronic transplant rejection, [[contact dermatitis]] | | IV: Cell-mediated, Delayed || Activated T cells against cell surface antigens || TB skin test, chronic transplant rejection, delayed drug rashes, [[contact dermatitis]] | ||
|} | |} | ||
Line 21: | Line 21: | ||
==References== | ==References== | ||
<references/> | <references/> | ||
[[Category:Dermatology]] [[Category:Rheumatology]] |
Latest revision as of 02:58, 2 March 2020
Background
- Uncomfortable, damaging, and sometimes fatal reactions produced by the normal immune system including allergies and autoimmunity.
Clinical Features
Type | Mechanism | Example |
---|---|---|
I: Allergy, Immediate | IgE-mediated degranulation of mast cells and basophils; usually happens after a first exposure which causes sensitization | Urticaria, anaphylaxis, angioedema |
II: Cytotoxic, Antibody Dependant | IgG or IgM antibodies react with cell antigens with resultant complement activation | Myasthenia gravis, goodpasture syndrome, erythroblastalis fetalis, AI hemolytic anemia, Graves disease |
III: Immune Complex | IgG immune complex deposition and subsequent complement activation | Serum sickness, RA, SLE, poststreptococcal glomerulonephritis |
IV: Cell-mediated, Delayed | Activated T cells against cell surface antigens | TB skin test, chronic transplant rejection, delayed drug rashes, contact dermatitis |